Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2019-02, Vol.184 (3), p.450-455
Hauptverfasser:	McGraw, Kathy L., Nguyen, Johnny, Al Ali, Najla H., Komrokji, Rami S., Sallman, David, Zhang, Xiaohui, Song, Jinming, Padron, Eric, Lancet, Jeffrey E., Moscinski, Lynn C., List, Alan F., Zhang, Ling
Format:	Artikel
Sprache:	eng
Schlagworte:	Cytogenetics Disease-Free Survival Enhancer of Zeste Homolog 2 Protein - biosynthesis Enhancer of Zeste Homolog 2 Protein - genetics EZH2 Female Gene Expression Regulation, Neoplastic Hematologic Neoplasms - genetics Hematologic Neoplasms - metabolism Hematologic Neoplasms - mortality Hematologic Neoplasms - pathology Hematology Humans Immunohistochemistry Male Mutation Myelodysplastic syndrome myelodysplastic syndromes Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - metabolism Myelodysplastic Syndromes - mortality Myelodysplastic Syndromes - pathology Neoplasm Proteins - biosynthesis Neoplasm Proteins - genetics survival Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!